Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Trading update

2 Nov 2010 07:00

RNS Number : 4177V
Arden Partners plc
02 November 2010
 

Arden Partners plc ("Arden" or the "Company")

 

Trading update

 

Arden (AIM: ARDN.L) today announces a trading update ahead of its close period relating to the year ended 31 October 2010.

On 10 September 2010 Arden issued a trading update to the effect that the Company would not meet market expectations. Since then the Company has completed two large corporate transactions and equity trading has been better than expected.

During the year ended 31 October 2010 the Company has rationalised its cost base and the Board now expects the Company to report a small net operating profit post charging exceptional items but before charging IFRS 2, share based payments. Exceptional items totalled some £800k. The Board believes that this will be a satisfactory result given difficult market trading conditions. The business has been cash generative for the year and at 31 October 2010 the Company had strong cash balances and regulatory capital.

The small and mid-cap market continues to be difficult but, with our corporate finance pipeline and a strong balance sheet, the Board believes that the Company is well positioned to take advantage of any upturn.

It is intended that the results for the year ended 31 October 2010 will be announced on 11 January 2011.

 

For further information, please contact:

 

Arden Partners plc 020 7614 5900

Jonathan Keeling - Chief Executive Officer

Trevor Norris - Group Finance Director

 

Altium  020 7484 4040

Phil Adams

 

Buchanan 020 7466 5000

Mark Edwards

James Strong

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKDDKCBDDCDK
Date   Source Headline
22nd Jan 201011:17 amRNSEPT Disclosure
20th Jan 201010:46 amRNSEPT Disclosure
11th Jan 201011:32 amRNSEPT Disclosure
7th Jan 201011:53 amRNSEPT Disclosure
5th Jan 201011:01 amRNSEPT Disclosure
4th Jan 201011:24 amRNSEPT Disclosure
31st Dec 200910:04 amRNSEPT Disclosure
23rd Dec 200911:46 amRNSEPT Disclosure
22nd Dec 200911:09 amRNSEPT Disclosure
21st Dec 200911:46 amRNSEPT Disclosure
18th Dec 20093:59 pmRNSEPT Disclosure
11th Dec 200911:30 amRNSEPT Disclosure
26th Nov 200911:59 amRNSEPT Disclosure
25th Nov 200911:40 amRNSEPT Disclosure
23rd Nov 200910:07 amRNSBlocklisting Return
16th Nov 200910:29 amRNSEPT Disclosure
2nd Nov 200911:38 amRNSTotal Voting Rights
14th Sep 20094:08 pmRNSEBT purchase
4th Sep 200911:20 amRNSEPT Disclosure
1st Sep 20091:59 pmRNSTotal Voting Rights
1st Sep 200910:31 amRNSEPT Disclosure
25th Aug 200910:01 amRNSEPT Disclosure
20th Aug 200911:23 amRNSEPT Disclosure
19th Aug 200911:29 amRNSEPT Disclosure
18th Aug 200910:24 amRNSEPT Disclosure
14th Aug 200910:21 amRNSEPT Disclosure
13th Aug 200911:28 amRNSEPT Disclosure
11th Aug 200911:41 amRNSEPT Disclosure - Amendment
11th Aug 200911:24 amRNSEPT Disclosure
10th Aug 20099:47 amRNSEPT Disclosure
6th Aug 20099:47 amRNSEPT Disclosure
5th Aug 200910:48 amRNSEPT Disclosure
31st Jul 20099:29 amRNSEPT Disclosure
30th Jul 200910:45 amRNSEPT Disclosure
24th Jul 20091:16 pmRNSDirector's dealing
24th Jul 200910:08 amRNSEPT Disclosure
23rd Jul 20099:19 amRNSEPT Disclosure
17th Jul 20091:44 pmRNSEBT Purchase
14th Jul 20097:00 amRNSInterim results
10th Jul 200910:08 amRNSEPT Disclosure
9th Jul 20099:56 amRNSEPT Disclosure
3rd Jul 20097:00 amRNSNotice of Results
1st Jul 20099:31 amRNSEPT Disclosure
25th Jun 20099:52 amRNSEPT Disclosure
24th Jun 200911:01 amRNSEPT Disclosure
23rd Jun 200910:17 amRNSEPT Disclosure
15th Jun 200912:13 pmRNSAndrew Heath Appointed Head of Equities
12th Jun 200910:43 amRNSEPT Disclosure
11th Jun 200910:15 amRNSEPT Disclosure
10th Jun 200910:26 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.